Logo image of CERT

CERTARA INC (CERT) Stock Overview

USA - NASDAQ:CERT - US15687V1098 - Common Stock

12.51 USD
-0.15 (-1.18%)
Last: 10/27/2025, 8:08:42 PM
12.51 USD
0 (0%)
Pre-Market: 10/28/2025, 4:48:45 AM

CERT Key Statistics, Chart & Performance

Key Statistics
Market Cap2.01B
Revenue(TTM)405.75M
Net Income(TTM)7.98M
Shares160.62M
Float120.10M
52 Week High15.69
52 Week Low8.64
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.49
PE25.53
Fwd PE22.56
Earnings (Next)11-05 2025-11-05/amc
IPO2020-12-11
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology


CERT short term performance overview.The bars show the price performance of CERT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

CERT long term performance overview.The bars show the price performance of CERT in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20

The current stock price of CERT is 12.51 USD. In the past month the price increased by 2.71%. In the past year, price increased by 22.05%.

CERTARA INC / CERT Daily stock chart

CERT Latest News, Press Relases and Analysis

CERT Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 39.69 48.47B
DOCS DOXIMITY INC-CLASS A 45.97 12.83B
WAY WAYSTAR HOLDING CORP 35.43 7.51B
HTFL HEARTFLOW INC N/A 3.20B
SDGR SCHRODINGER INC N/A 1.63B
TDOC TELADOC HEALTH INC N/A 1.59B
PHR PHREESIA INC N/A 1.41B
GDRX GOODRX HOLDINGS INC-CLASS A 10.77 1.31B
CTEV CLARITEV CORP N/A 1.18B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.07B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 900.15M
EVH EVOLENT HEALTH INC - A N/A 897.78M

About CERT

Company Profile

CERT logo image Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Radnor, Pennsylvania and currently employs 1,487 full-time employees. The company went IPO on 2020-12-11. The company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. The company delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. The company offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.

Company Info

CERTARA INC

4 Radnor Corporate Center, Suite 350

Radnor PENNSYLVANIA 08540 US

CEO: William F. Feehery

Employees: 1517

CERT Company Website

CERT Investor Relations

Phone: 14152378272

CERTARA INC / CERT FAQ

What does CERT do?

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Radnor, Pennsylvania and currently employs 1,487 full-time employees. The company went IPO on 2020-12-11. The company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. The company delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. The company offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.


Can you provide the latest stock price for CERTARA INC?

The current stock price of CERT is 12.51 USD. The price decreased by -1.18% in the last trading session.


What is the dividend status of CERTARA INC?

CERT does not pay a dividend.


How is the ChartMill rating for CERTARA INC?

CERT has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Which stock exchange lists CERT stock?

CERT stock is listed on the Nasdaq exchange.


What sector and industry does CERTARA INC belong to?

CERTARA INC (CERT) operates in the Health Care sector and the Health Care Technology industry.


Can you provide the market cap for CERTARA INC?

CERTARA INC (CERT) has a market capitalization of 2.01B USD. This makes CERT a Mid Cap stock.


CERT Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to CERT. When comparing the yearly performance of all stocks, CERT is one of the better performing stocks in the market, outperforming 82.82% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CERT Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CERT. CERT has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CERT Financial Highlights

Over the last trailing twelve months CERT reported a non-GAAP Earnings per Share(EPS) of 0.49. The EPS increased by 32.43% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.97%
ROA 0.52%
ROE 0.75%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%12.06%
EPS 1Y (TTM)32.43%
Revenue 1Y (TTM)11.61%

CERT Forecast & Estimates

18 analysts have analysed CERT and the average price target is 14.73 USD. This implies a price increase of 17.77% is expected in the next year compared to the current price of 12.51.

For the next year, analysts expect an EPS growth of -0.92% and a revenue growth 9.9% for CERT


Analysts
Analysts75.56
Price Target14.73 (17.75%)
EPS Next Y-0.92%
Revenue Next Year9.9%

CERT Ownership

Ownership
Inst Owners81.56%
Ins Owners2.42%
Short Float %13.21%
Short Ratio9.57